홈600812 • SHA
add
North China Pharmaceutical Co Ltd
시장 뉴스
재무
손익계산서
수익
순이익
(CNY) | 2024년 9월info | 전년대비 변동 |
---|---|---|
수익 | 23.29억 | -15.04% |
운영비 | 5.39억 | -19.20% |
순이익 | 3047.92만 | 2,035.14% |
순이익률 | 1.31 | 2,520.00% |
주당 수익 | — | — |
EBITDA | 3.63억 | 6.65% |
유효 세율 | 32.92% | — |
대차대조표
총자산
총부채
(CNY) | 2024년 9월info | 전년대비 변동 |
---|---|---|
현금 및 단기 투자 | 17.22억 | 15.99% |
총자산 | 217.07억 | 0.92% |
총부채 | 151.01억 | -0.95% |
총자기자본 | 66.06억 | — |
발행 주식 | 17.16억 | — |
주가순자산비율 | 1.61 | — |
총자산이익률 | 2.06% | — |
자본이익률 | 2.47% | — |
현금 흐름
순현금흐름
(CNY) | 2024년 9월info | 전년대비 변동 |
---|---|---|
순이익 | 3047.92만 | 2,035.14% |
영업 현금 흐름 | 1.75억 | -46.70% |
투자 현금 흐름 | -1.53억 | 10.80% |
자금 조달 현금 흐름 | -7680.19만 | 67.74% |
순현금흐름 | -5537.75만 | 30.27% |
잉여 현금 흐름 | -6.61억 | -459.21% |
정보
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
설립
1992. 12. 20.
직원 수
10,159